Michaela Fojtů
Senior Scientist, Preclinical Pharmacology SOTIO Biotech a.s.
Seminars
Monday 3rd November 2025
Presentation Sneak Peek:
Showcasing Novel Pharmacology & Translational Aspects of SOT106 Targeting LRRC15 in Solid Tumors
- Describing pharmacological characterization of SOT106, including LRRC15 expression within different cell populations in the TME with emphasis on pivotal role in tumor biology
- Developing SOT106 diagnostic antibody tailored to optimize patient selection to identify those who could benefit from therapy
- Exploring the potential of SOT106 combination therapies and how these approaches can elevate its full therapeutic potential
